These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Richard Bergström. Interview by Asher Mullard. Bergström R Nat Rev Drug Discov; 2011 Jun; 10(6):408. PubMed ID: 21629284 [No Abstract] [Full Text] [Related]
6. An audience with Guido Rasi. Interview by Asher Mullard. Rasi G Nat Rev Drug Discov; 2012 Mar; 11(3):182. PubMed ID: 22378260 [No Abstract] [Full Text] [Related]
7. Mark McClellan. Interview by Asher Mullard. McClellan M Nat Rev Drug Discov; 2012 Sep; 11(9):668. PubMed ID: 22935796 [No Abstract] [Full Text] [Related]
8. Traditional drug-discovery model ripe for reform. Cressey D Nature; 2011 Mar; 471(7336):17-8. PubMed ID: 21368796 [No Abstract] [Full Text] [Related]
9. David Haslam. Interview by Asher Mullard. Haslam D Nat Rev Drug Discov; 2013 Jul; 12(7):500. PubMed ID: 23764976 [No Abstract] [Full Text] [Related]
10. Paul Stoffels. Interview by Asher Mullard. Stoffels P Nat Rev Drug Discov; 2013 Apr; 12(4):258. PubMed ID: 23535929 [No Abstract] [Full Text] [Related]
11. Translational regenerative medicine research: essential to discovery and outcome. Mason C; Dunnill P Regen Med; 2007 May; 2(3):227-9. PubMed ID: 17511558 [No Abstract] [Full Text] [Related]
12. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy. Lee JA; Uhlik MT; Moxham CM; Tomandl D; Sall DJ J Med Chem; 2012 May; 55(10):4527-38. PubMed ID: 22409666 [No Abstract] [Full Text] [Related]
14. Michael Snyder. Interview by Asher Mullard. Snyder M Nat Rev Drug Discov; 2012 Oct; 11(10):744. PubMed ID: 23023673 [No Abstract] [Full Text] [Related]
15. Virtual drug discovery with the rise of Chinese CROs. Zhang MQ Drug Discov Today; 2010 Sep; 15(17-18):693-7. PubMed ID: 20685343 [No Abstract] [Full Text] [Related]
16. Charles Hugh-Jones. Interview by Asher Mullard. Hugh-Jones C Nat Rev Drug Discov; 2013 Dec; 12(12):900. PubMed ID: 24287774 [No Abstract] [Full Text] [Related]
17. The role of discovery DMPK scientists in industry: where do we go from here? Moriwaki T Drug Metab Pharmacokinet; 2012; 27(2):169-70. PubMed ID: 22531680 [No Abstract] [Full Text] [Related]
18. 2011 in reflection. Mullard A Nat Rev Drug Discov; 2012 Jan; 11(1):6-8. PubMed ID: 22212664 [No Abstract] [Full Text] [Related]
19. Affairs of the Heart: Innovation in Cardiovascular Research and Development. Honig P; Terzic A Clin Pharmacol Ther; 2017 Aug; 102(2):162-168. PubMed ID: 28718903 [TBL] [Abstract][Full Text] [Related]
20. An industrial perspective on contemporary applications of PBPK models in drug discovery and development. Smith BJ Biopharm Drug Dispos; 2012 Mar; 33(2):53-4. PubMed ID: 22407480 [No Abstract] [Full Text] [Related] [Next] [New Search]